GEC 052t
Alternative Names: GEC-052tLatest Information Update: 12 Jul 2022
At a glance
- Originator GenEros BioPharma
- Class Antineoplastics
- Mechanism of Action Signal transducing adaptor protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours
Most Recent Events
- 20 Jun 2022 Preclinical trials in Solid tumours in China (unspecified route) (GenEros Biopharma pipeline, June 2022)